Spinal Tethering for Scoliosis
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Studies on anterior vertebral body tethering (AVBT) for scoliosis show that it has some risks, with about 3.3% of patients experiencing major complications like fluid buildup in the chest or nerve issues, and another 3.3% having minor issues like nausea or wound infections. However, no patients needed blood transfusions, and most complications were manageable.
12345Anterior Vertebral Body Tethering (AVBT) is unique because it corrects scoliosis without the need for spinal fusion, allowing for continued growth and flexibility in the spine. Unlike traditional methods that involve fusing the spine, AVBT uses a flexible cord to guide the spine's growth, making it a promising option for children who are still growing.
13678Eligibility Criteria
This trial is for skeletally immature children with idiopathic scoliosis who have a major Cobb angle between 30° and 65°, have not had prior spinal surgery at the levels to be treated, and are unable to use bracing. They must also be able to return for follow-up visits and agree to participate in study procedures.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo anterior vertebral body tethering surgery
Follow-up
Participants are monitored for complications and spine growth outcomes
Participant Groups
Anterior Vertebral Body Tethering is already approved in United States for the following indications:
- Progressive idiopathic scoliosis in skeletally immature patients with a major Cobb angle of 30 to 65 degrees